As online and social media platforms increasingly serve as conduits for falsified medicines, global stakeholders are advancing innovative responses to curb this threat. This solutions-oriented session will spotlight lessons learned from industry, enforcement, and policy collaborations that have successfully disrupted illicit sales networks. Panelists will discuss real-world case studies, digital investigation approaches, and coordinated actions between the private sector, law enforcement, and public health agencies. The session will highlight practical pathways for building resilient systems that detect, deter, and dismantle the online trade in falsified medicines while protecting vulnerable populations from digital exploitation.
As online and social media platforms increasingly serve as conduits for falsified medicines, global stakeholders are advancing innovative responses to curb this threat. This solutions-oriented session will spotlight lessons learned from industry, enforcement, and policy collaborations that have successfully disrupted illicit sales networks. Panelists will discuss real-world case studies, digital investigation approaches, and coordinated actions between the private sector, law enforcement, and public health agencies. The session will highlight practical pathways for building resilient systems that detect, deter, and dismantle the online trade in falsified medicines while protecting vulnerable populations from digital exploitation.
BESAFE2025 besafe@jh.edu
Technical Issues?
If you're experiencing playback problems, try adjusting the quality or refreshing the page.
Questions for Speakers?
Use the Q&A tab to submit questions that may be addressed in follow-up sessions.
